Wells Fargo’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-841
Closed -$4.94K 7835
2023
Q4
$4.94K Sell
841
-1,852
-69% -$21.9K ﹤0.01% 5956
2023
Q3
$68.3K Sell
2,693
-305
-10% -$25.1K ﹤0.01% 5008
2023
Q2
$417K Buy
2,998
+595
+25% +$76.4K ﹤0.01% 4086
2023
Q1
$219K Buy
2,403
+309
+15% +$41.9K ﹤0.01% 4369
2022
Q4
$287K Buy
2,094
+1,533
+273% +$519K ﹤0.01% 3978
2022
Q3
$486K Buy
561
+354
+171% +$222K ﹤0.01% 3699
2022
Q2
$91K Sell
207
-19
-8% -$9.91K ﹤0.01% 4698
2022
Q1
$144K Sell
226
-447
-66% -$282K ﹤0.01% 5152
2021
Q4
$600K Sell
673
-122
-15% -$128K ﹤0.01% 4524
2021
Q3
$1.01M Buy
795
+232
+41% +$281K ﹤0.01% 4238
2021
Q2
$682K Sell
563
-88
-14% -$119K ﹤0.01% 4458
2021
Q1
$862K Sell
651
-197
-23% -$279K ﹤0.01% 4354
2020
Q4
$1.14M Buy
848
+246
+41% +$281K ﹤0.01% 3937
2020
Q3
$627K Buy
+602
New +$629K ﹤0.01% 4185

Other funds holding CANO

Wells Fargo's CANO Position: Q1 2024 in Review

Wells Fargo sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 841 shares — an estimated $4.94K sold.

Wells Fargo first reported a position in CANO in Q3 2020 and held it in 14 quarters. The position peaked at $1.14M in Q4 2020. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Wells Fargo reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 841 Cano Health, Inc. shares in Q1 2024, an estimated $4.94K.
  • Wells Fargo first reported a position in Cano Health, Inc. in Q3 2020 and held it in 14 quarters.
  • Wells Fargo's Cano Health, Inc. position peaked at $1.14M in Q4 2020.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.